Holen Sie sich die Stockscreener-App
2.37
5.22%
0.07
Handel nachbörslich:
2.41
0.04
+1.69%
Schlusskurs vom Vortag:
$2.30
Offen:
$2.32
24-Stunden-Volumen:
101.69K
Relative Volume:
0.30
Marktkapitalisierung:
$7.91M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-1.1075
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
-5.10%
1M Leistung:
-1.63%
6M Leistung:
-15.09%
1J Leistung:
+0.83%
1-Tages-Spanne:
$2.23
$2.45
1-Wochen-Bereich:
$2.23
$2.56
52-Wochen-Spanne:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie CYCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.37 | 7.37M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Should you hold or exit Cyclerion Therapeutics Inc. nowJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
Can momentum traders help lift Cyclerion Therapeutics Inc.Quarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-13 10:09:21 - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsJuly 2025 Update & Fast Gain Swing Alerts - newser.com
Pattern recognition hints at Cyclerion Therapeutics Inc. upsideForecast Cut & Precise Buy Zone Identification - newser.com
How to recover losses in Cyclerion Therapeutics Inc. stockTrade Ideas & Long Hold Capital Preservation Tips - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastMarket Insider Reports & Build Balanced Portfolio - earlytimes.in
Leading vs lagging indicators on Cyclerion Therapeutics Inc. performanceIndex Update & Free Community Supported Trade Ideas - newser.com
Will Cyclerion Therapeutics Inc. stock recover faster than peers2025 Stock Rankings & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-09 06:28:37 - newser.com
Is Cyclerion Therapeutics Inc. stock ready for a breakoutJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-09 05:00:18 - newser.com
Detecting support and resistance levels for Cyclerion Therapeutics Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
What MACD signals say about Cyclerion Therapeutics Inc.July 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Trend Bullish continuation from March 2025Sector-Based Investing & Rapid Portfolio Strategies - earlytimes.in
Best data tools to analyze Cyclerion Therapeutics Inc. stockJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com
Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Technicals & Verified Entry Point Signals - newser.com
Cyclerion Therapeutics Inc. stock volume spike explainedTrade Signal Summary & Short-Term High Return Strategies - newser.com
Will Cyclerion Therapeutics Inc. price bounce be sustainableJobs Report & Short-Term Swing Trade Alerts - newser.com
What drives Cyclerion Therapeutics Inc stock pricePortfolio Diversification Tips & Affordable Market Trading - earlytimes.in
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):